NASDAQ NMS - GLOBAL MARKET · CVRX
-0.01% · $0.0000 · Vol 520.4K
Market closed · last close 4:00 PM ET · price as of 19:17:51 ET
CVRx Inc

CVRx Inc

Health Care
$1.67
Card
Relationship Map

Follow $CVRX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CVRX by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
CVRX
CVRx Inc
Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Lower range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

34/ 100
Veridion Score
Lower range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Thu Oct 8 · market closed · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CVRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CVRX catalysts
About CVRx Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
223
Country
US

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.64
Day high
$1.68
Day low
$1.55
Previous close
$1.67
52W high
$10.81
-84.55% from high
52W low
$1.53
2% of range
Market cap
$44.5M
EPS
$-1.9742
Beta
0.35
Shares out
26.6M
Volume
520.4K
0.70× rel vol
Avg volume
742.2K
VWAP
$1.65
Price history computed in-house
1W
+7.74%
1M
-40.99%
3M
-69.25%
1Y
-81.77%
YTD
-76.48%
SMA 50 $3.02 · below
SMA 200 $5.77 · below
52W position 2%

CVRX overview

Veridion Score
34
Registered · 2026-10-08
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CVRX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CVRX Form 4 filings
Public disclosures

Congress activity in CVRX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

CVRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CVRX in this window.
Lobbying spend

CVRX lobbying filings, year to date.

Registered lobbying filings matched to CVRx Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CVRX in this window.
Loading news for CVRX
Analyst ratings
Sovereign unlock shows live analyst consensus for CVRX.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.